Almac Diagnostic Services partnered with PredictImmune to develop and validate the gene expression software algorithm used to interpret the results from the world’s first validated and CE-marked prognostic test for Inflammatory Bowel Disease (IBD).

PredictImmune selected Almac as their preferred provider for bioinformatics, software design & development solutions to support the successful commercialisation and launch of the PredictSURE IBD™ test.